HEALTH

PARIS — Sanofi on Monday announced that its U.S. Consumer Healthcare Division Chattem, completed the acquisition of the worldwide rights to the Rolaids brand from McNeil Consumer Healthcare for an undisclosed amount.

NEW ORLEANS — Consumers measure the risk of contracting the flu to the price of their flu shot, according to research out of Tulane University released Friday. 

The study found that consumers make judgments about their risk of catching any illness based on the cost of its medication. The higher the price, the less they think they’re at risk, stated co-author Janet Schwartz, assistant professor of marketing at Tulane’s A.B. Freeman School of Business.

CHICAGO — Sales of smoking cessation aids are projected to reach $1 billion in 2012 with continued growth driving sales as high as $1.2 billion by 2017, market research firm Mintel reported Thursday. 

PRINCETON, N.J. — Novo Nordisk has appointed Curtis Oltmans as its corporate VP and general counsel for legal and quality affairs, the company said Friday.

In the new role, for which he will also join the company's U.S. executive team, Oltmans will be handle issues like law, quality, intellectual property, grants and philanthropy for the Danish drug maker's North American business.

UNIVERSAL CITY, Calif. — NBCUniversal Television Consumer Products, in conjunction with Shine America, on Thursday announced the launch of the newly enhanced Biggestloser.com to serve as a one-stop portal with complete access to NBC’s “The Biggest Loser” online community.

SUNBURY, Pa. — Weis Markets on Friday announced the launch of its 10th round of price freezes, effective in all 163 store locations. 

More than 2,000 products have been reduced in price and will stay at these discounted levels for 90 days. Since the company began its price freezing initiative in January 2009, Weis customers have saved more than $40 million dollars, the grocer stated.

NEW YORK — According to a Bloomberg report published Friday morning, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion. 

B&L is being shopped by private equity firm Warburg Pincus, which is working with Goldman Sachs Group, Bloomberg reported, and both Abbott and Sanofi have contracted financial advisors as well. 

Other companies who have been invited to bid include Merck and Pfizer. 

LAS VEGAS — Technology and sexual health will merge at the 2013 International Consumer Electronics Show here with executives from Standard Innovation making feature presentations and Church & Dwight targeting the show with a personal massager giveaway as part of its campaign to initiate a trial that started in November 2012.